Target intelligence / Profile preview

cAMP response element-binding protein-regulated transcription co-activator 1 (CRTC1)

Target
CRTC1
Molecular classification
Transcription co-activator
01

Overview

cAMP response element-binding protein-regulated transcription co-activator 1 (CRTC1) is a key transcriptional co-activator that mediates cellular responses to cAMP and calcium signaling by enhancing the activity of the CREB transcription factor [1, 3]. Under basal conditions, CRTC1 is phosphorylated by Salt-inducible kinases (SIKs) and sequestered in the cytoplasm; upon activation, it is dephosphorylated by calcineurin and translocates to the nucleus to bind CREB and promote the expression of genes involved in metabolism, memory, and circadian rhythms [1, 7, 12]. In clinical oncology, CRTC1 is most prominent as a fusion partner, where the CRTC1-MAML2 translocation acts as the primary driver for mucoepidermoid carcinoma, a common salivary gland malignancy [13, 15]. Additionally, novel fusions like CRTC1-TRIM11 have been identified as drivers in specific cutaneous melanocytic tumors [17, 18]. Beyond cancer, CRTC1 dysregulation is implicated in neurodegenerative conditions like Alzheimer's disease and metabolic disorders like obesity [6, 10]. While direct pharmacological inhibition of CRTC1 remains a therapeutic challenge, experimental small molecules like 666-15 target its interaction with CREB, and indirect modulation is explored via SIK inhibitors or downstream targeting of CRTC1 fusion signaling pathways [13, 16].

Other names
CREB-regulated transcription coactivator 1Transducer of regulated cAMP response element-binding protein 1TORC1MECT1WAMTP1Mucoepidermoid carcinoma translocated protein 1
02

Mechanism of action

CRTC1 acts as a co-activator by binding to the basic leucine zipper (bZIP) domain of the transcription factor CREB (cAMP response element-binding protein), thereby enhancing its ability to recruit the transcriptional machinery (such as TAF4 and CBP/p300) to cAMP-responsive elements (CRE) in target gene promoters [1, 3, 7]. Its activity is regulated by its subcellular localization: phosphorylation by Salt-inducible kinases (SIK) leads to cytoplasmic sequestration by 14-3-3 proteins, while dephosphorylation by calcineurin triggers nuclear translocation and activation [1, 3, 12].

03

Biological functions

Signal transductionGene expression regulationGlucose metabolismCircadian rhythm regulationSynaptic plasticityEnergy homeostasisAlternative splicing
04

Disease associations

CancerMucoepidermoid carcinomaAlzheimer's diseaseObesityMajor depressive disorderDiabetes mellitusAcute lung injury
05

Safety considerations

Metabolic disruption (e.g., risk of hypoglycemia due to regulation of gluconeogenesis)Neurocognitive side effects (given its role in long-term memory and synaptic plasticity)Circadian rhythm disruptionPleiotropic effects due to the broad nature of transcription co-activation
06

Interacting drugs

666-15

7 more in the full profile.

07

Biomarkers

CRTC1-MAML2 fusion protein (t(11;19)(q21;p13) translocation)CRTC1-TRIM11 fusionCRTC1-SS18 fusionSer-151 phosphorylation statusNuclear localization of CRTC1

Beyond the preview

Go deeper on cAMP response element-binding protein-regulated transcription co-activator 1 (CRTC1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cAMP response element-binding protein-regulated transcription co-activator 1 (CRTC1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call